在疾病中研究Limosilactibacilus reuteri的进展
Zhuoru Jiang1, Ping Jiang1, Siqi Ji2
1Department of Gastroenterology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing 210093, China.
Microbiological research
|September 3, 2023
概括
莱莫西拉克提巴西勒 (L. reuteri) 是一种益生菌. 虽然通常是有益的,但一些菌株可能会恶化疾病,需要进一步研究其在人类健康中的作用.
科学领域:
- 微生物学 微生物学
- 益生菌 益生菌 益生菌
- 我们的肠道微生物群.
背景情况:
- 莱莫西拉克提巴西勒 (Limosilactibacilus reuteri,L. reuteri) 是一种格拉姆阳性益生菌.
- 在中国,某些菌株已被批准用于人类健康产品.
- L. reuteri 在肠道健康和免疫功能方面发挥作用.
研究的目的:
- 审查L. reuteri. 的研究历史.
- 阐明L. reuteri影响宿主健康和疾病的机制.
- 讨论L. reuteri在健康和疾病中的双重作用.
主要方法:
- 对L. reuteri.现有研究的文献综述.
- 对L. reuteri对宿主生物的直接和间接影响的分析.
- 检查L. reuteri与各种疾病的关联.
主要成果:
- L. reuteri调节肠道微生物群和宿主生理.
- 缺乏L. reuteri与消化,自身免疫,内分泌和生殖系统疾病有关.
- 一些研究表明L. reuteri可以促进疾病的进展.
结论:
- L. reuteri 具有双重作用,通常是有益的,但有可能加剧疾病.
- 需要进一步的研究才能充分了解L. reuteri的影响及其作为益生菌的未来.
- 对于L. reuteri的健康益处和疾病恶化的机制需要更深入的研究.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
01:21Drugs for Treatment of Constipation-Predominant IBS
206
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
206